Vext Science

Join the Vext C-suite on April 23 at 2:00pm ET for an in-depth discussion on our vertically integrated, retail-driven footprint in Ohio and Arizona, insights into how we’re navigating the evolving cannabis landscape, and more. Register here: https://lnkd.in/gDNfVEtE #Cannabis #VextScience #VEXT #VEXTF

Vext announced the sale of a medical cannabis processing license in Kentucky. “This transaction underscores our disciplined approach to capital allocation and strategic focus on maximizing returns in our core markets,” said Eric Offenberger, CEO of Vext. “By divesting the processing license in Kentucky, we are deepening our focus on our core operations in Arizona and Ohio, where we see the most compelling opportunities to drive long-term value. The proceeds of the sale strengthen our balance sheet and will support the build-out of our Ohio retail footprint as we continue to prioritize profitability and cash flow growth across our vertically-integrated operations.” More details here: https://lnkd.in/gEA2ziSr #VEXT #VEXTF #Cannabis

This morning Vext announced that it has completed the Ohio Expansion Transaction doubling its retail footprint in the state. Ohio remains a key market for Vext, and the Company remains on track to reach the state license cap of eight dispensaries, with new locations expected to open in 2025 and early 2026. Find more details in the press release: https://lnkd.in/g4wWDkKU #VEXT #VEXTF #Ohio #Cannabis

Vext Science has reported its Q4 and Fiscal 2024 financial results, marking its strongest operating quarter in recent years. The Company delivered growth across revenue, adjusted EBITDA, and cash flow, reflecting the strength of its operations and disciplined execution. Details here: https://lnkd.in/gNReaWKB Vext will host a conference call and webcast today at 8:00 a.m. ET to discuss its fourth quarter and full-year 2024 financial results. Listen to the webcast here: https://lnkd.in/gtNqzAF7 #VEXT #VEXTF

Vext Science will release its financial results for the period ended December 31, 2024, before market open on March 31, 2025. A conference call and webcast will be held the same day at 8:00 a.m. ET to discuss the results. Learn more here: https://lnkd.in/g7BGwUck #VextScience #Cannabis #VEXT #VEXTF

Vext has relocated and doubled the size of its Herbal Wellness Center dispensary in Jackson, Ohio. Situated in a more central location within Jackson, the new dispensary features an expanded retail space and inventory capacity, offers patients and customers a wide product selection and improves service through a convenient drive-thru window. Read more: https://lnkd.in/g45FqmbN #VEXT #VEXTF

Our CEO, Eric Offenberger, will join Jushi Holdings Inc. and Zuanic & Associates LLC to discuss the competitive landscape, regulatory outlook, and market opportunities in Ohio. 📅 Feb 13 | 2 PM ET Register here: https://lnkd.in/d_Pga4cM | Or join us on X Spaces: https://lnkd.in/drefynz6 #VEXT #VEXTF

Vext secured its 5th Ohio dispensary location. This milestone positions us to capitalize on market growth in Ohio. With our cultivation and retail operations approaching full capacity, we’re focused on driving sustainable cash flow growth and creating long-term value for our shareholders. Read the full announcement here: https://lnkd.in/gDRBCGat. #VEXTF

According to the Ohio Medical Marijuana Control Program, total adult-use #cannabis sales exceeded $160M as of November 16, 2024. Download our latest investor relations presentation to learn more about #VEXT’s Ohio footprint https://lnkd.in/gXy8jANW. #VEXTF

Last week #VEXT reported solid financial results for Q3 2024 which is a testament to the team's disciplined execution amid persistent macroeconomic headwinds. This demonstrates the resilience of Vext’s business model and the strength of our customer relationships, positioning Vext favourably with customers as the Arizona market continues to stabilize. Click here https://lnkd.in/gurF-XTw to access a recording of the Q3 2024 webcast. #VEXTF